Potency testing for the experimental Na-GST-1 hookworm vaccine

References

• Hotez PJ, Molyneux DH, Fenwick A et al. Control of neglected tropical diseases. N. Engl. J. Med.357(10), 1018–1027 (2007).
   PubMedGoogle Scholar
• Arciniega JL. What’s in a name? The meaning of the term ‘potency’, as applied to immunobiologicals for human use, and its implications for alternatives and validation. In: Progress in the Reduction, Refinement and Replacement of Animal Experimentation. Balls M, van Zeller A-M, Halder ME (Eds). Elsevier, Amsterdam, The Netherlands, 979–986 (2000).
   Google Scholar
• Hendriksen C, Arciniega JL, Bruckner L et al. The consistency approach for the quality control of vaccines. Biologicals36(1), 73–77 (2008).
   PubMed Web of Science ®Google Scholar
• Hotez PJ, Bethony J, Bottazzi ME et al. Hookworm: ‘the great infection of mankind’. PLoS Med.2(3), 187 (2005).
   Google Scholar
• Bethony J, Brooker S, Albonico M et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet367(9521), 1521–1532 (2006).
   PubMed Web of Science ®Google Scholar
• Brooker S, Bethony J, Hotez PJ. Human hookworm infection in the 21st Century. Adv. Parasitol.58, 197–288 (2004).
   PubMed Web of Science ®Google Scholar
• Keiser J, Utzinger J. Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. JAMA299(16), 1937–1948 (2008).
   PubMed Web of Science ®Google Scholar
• Williamson AL, Brindley PJ, Knox DP et al. Digestive proteases of blood-feeding nematodes. Trends Parasitol.19(9), 417–423 (2003).
   PubMedGoogle Scholar
• Williamson AL, Lecchi P, Turk BE et al. A multi-enzyme cascade of hemoglobin proteolysis in the intestine of blood-feeding hookworms. J. Biol. Chem.279(34), 35950–35957 (2004).
   PubMedGoogle Scholar
• Ranjit N, Zhan B, Hamilton B et al. Proteolytic degradation of hemoglobin in the intestine of the human hookworm Necator americanus.J. Infect. Dis.199(6), 904–912 (2009).
   PubMed Web of Science ®Google Scholar
• Hotez PJ, Ferris MT. The antipoverty vaccines. Vaccine24(31–32), 5787–5799 (2006).
   PubMed Web of Science ®Google Scholar
• Zhan B, Liu S, Perally S et al. Biochemical characterization and vaccine potential of a heme-binding glutathione transferase from the adult hookworm Ancylostoma caninum.Infect. Immun.73(10), 6903–6911 (2005).
   PubMed Web of Science ®Google Scholar
• Zhan B, Brophy P, Perally S et al. Molecular cloning, biochemical characterization and partial protective immunity of the heme-binding glutathione S- transferases from the human hookworm Necator americanus.Infect. Immun.78(4), 1552–1563 (2010).
   PubMed Web of Science ®Google Scholar
• van Rossum AJ, Jefferies JR, Rijsewijk FAM et al. Binding of hematin by a new class of glutathione transferase from the blood-feeding parasitic nematode Haemonchus contortus.Infect. Immun.72(5), 2780 (2004).
   Google Scholar
• Schuller DJ, Liu Q, Kriksunov IA et al. Crystal structure of a new class of glutathione transferase from the model human hookworm nematode Heligmosomoides polygyrus.Proteins Struct. Funct. Bioinformat.61, 1024–1031 (2005).
   PubMed Web of Science ®Google Scholar
• Asojo OA, Homma K, Sedlacek M et al. X-ray structures of Na-GST-1 and Na-GST-2 two glutathione S- transferase from the human hookworm Necator americanus.BMC Struct. Biol.7, 42 (2007).
   PubMed Web of Science ®Google Scholar
• Xiao S, Zhan B, Xue J et al. The evaluation of recombinant hookworm antigens as vaccines in hamsters (Mesocricetus auratus) challenged with human hookworm, Necator americanus.Exp. Parasitol.118(1), 32–40 (2008).
   PubMed Web of Science ®Google Scholar
• Hendriksen CFM. Replacement, reduction and refinement alternatives to animal use in vaccine potency measurement. Expert Rev. Vaccines8(3), 313–322 (2009).
   Web of Science ®Google Scholar
• US Code of Federal Regulations, 21 CFR §600.3 (s). Department of Health and Human Services, US FDA, MD, USA (2009).
   Google Scholar
• Q6B: Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Geneva, Switzerland (1999).
   Google Scholar
• Fujiwara RT, Zhan B, Mendez S et al. Reduction of worm fecundity and canine host blood loss mediates protection against hookworm infection elicited by vaccination with recombinant Ac-16. Clin. Vaccine Immunol.14(3), 281 (2007).
   PubMedGoogle Scholar
• Miller TA. Industrial development and field use of the canine hookworm vaccine. Adv. Parasitol.16, 333–342 (1978).
   PubMedGoogle Scholar
• Miller TA. Vaccination against the canine hookworm diseases. Adv. Parasitol.9, 153–183 (1971).
   PubMedGoogle Scholar
• Miller TA. Transfer of immunity to Ancylostoma caninum infection in pups by serum and lymphoid cells. Immunology12(2), 231–241 (1967).
   PubMedGoogle Scholar
• Xue J, Hui-Qing Q, Jun-Ming Y et al.Necator americanus: optimization of the golden hamster model for testing anthelmintic drugs. Exp. Parasitol.111(4), 219–223 (2005).
   Google Scholar
• Petricciani J, Egan W, Vicari G et al. Potency assays for therapeutic live whole cell cancer vaccines. Biologicals35(2), 107–113 (2007).
   Google Scholar
• Giersing BK, Dubovsky F, Saul A et al. Potency assay design for adjuvanted recombinant proteins as malaria vaccines. Vaccine24(20), 4264–4270 (2006).
   PubMed Web of Science ®Google Scholar
• Finney DJ. Probit Analysis. University Press, Cambridge, UK (1971).
   Google Scholar
• Voller A, Bartlett A, Bidwell D. Enzyme immunoassays with special reference to ELISA techniques. J. Clin. Pathol.31(6), 507–520 (1978).
   PubMed Web of Science ®Google Scholar
• Voller A. The enzyme-linked immunosorbent assay (ELISA) (theory, technique and applications). Ric. Clin. Lab.8(4), 289–298 (1978).
   Google Scholar
• Crowther JR. The ELISA Guidebook. Humana Press, NJ, USA (2001).
   Google Scholar
• Miura K, Orcutt AC, Muratova OV et al. Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines. Vaccine26(2), 193–200 (2007).
   Google Scholar
• Plikaytis BD, Carlone GM. Statistical considerations for vaccine immunogenicity trials part 1: introduction and bioassay design and analysis. Vaccine23(13), 1596–1605 (2005).
   PubMed Web of Science ®Google Scholar
• Quinn CP, Semenova VA, Elie CM et al. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg. Infect. Dis.8(10), 1103–1110 (2002).
   PubMed Web of Science ®Google Scholar
• Armbruster DA, Pry T. Limit of blank, limit of detection and limit of quantitation. Clin. Biochem. Rev.29(Suppl. 1), S49–S52 (2008).
   PubMedGoogle Scholar
• Buncher CR, Tsay JY. Statistics in the Pharmaceutical Industry. Chapman & Hall/CRC, FL, USA (2006).
   Google Scholar
• European Pharmacopoeia Commission. Statistical analysis of results of biological assays and tests. In: European Pharmacopoeia, 6th edition. Council of Europe, Strasbourg, France, 571–600 (2008).
   Google Scholar